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Mitochondrial transcription termination factor 1,
MTERF1, has been reported to couple rRNA gene
transcription initiation with termination and is there-
fore thought to be a key regulator of mammalian
mitochondrial ribosome biogenesis. The prevailing
model is based on a series of observations published
over the last two decades, but no in vivo evidence
exists to show that MTERF1 regulates transcription
of the heavy-strand region of mtDNA containing the
rRNA genes. Here, we demonstrate that knockout
of Mterf1 in mice has no effect on mitochondrial
rRNA levels or mitochondrial translation. Instead,
loss of Mterf1 influences transcription initiation at
the light-strand promoter, resulting in a decrease
of de novo transcription manifested as reduced
7S RNA levels. Based on these observations, we
suggest that MTERF1 does not regulate heavy-
strand transcription, but rather acts to block
transcription on the opposite strand of mtDNA to
prevent transcription interference at the light-strand
promoter.
INTRODUCTION
The mitochondrial DNA (mtDNA) encodes 13 of the 90 respira-
tory chain subunits, and oxidative phosphorylation collapses in
the absence of mtDNA expression (Larsson et al., 1998). The
importance of mtDNA is further underscored by abundant
reports that point mutations and deletions of mtDNA cause
human diseases (Smeitink et al., 2006) and are implicated in
the aging process (Krishnan et al., 2007; Larsson, 2010).
Mitochondrial transcription initiation is absolutely dependent
on three different proteins: the mitochondrial RNA polymerase
(POLRMT) (Ringel et al., 2011), mitochondrial transcription factor618 Cell Metabolism 17, 618–626, April 2, 2013 ª2013 Elsevier Inc.B2 (TFB2M) (Falkenberg et al., 2002; Metodiev et al., 2009; Solo-
gub et al., 2009), andmitochondrial transcription factor A (TFAM)
(Falkenberg et al., 2002, 2007; Shi et al., 2012). The two strands
of the mtDNA molecule are known as heavy (H) and light (L)
strands, respectively. L-strand transcription is initiated from
a single promoter (LSP) and produces near genomic-length tran-
scripts necessary for expression of L-strand genes. In addition,
termination of transcription initiated at the LSP provides the
RNA primers necessary for initiation of mtDNA replication. The
H strand has been reported to contain two differentially regulated
promoters, HSP1 and HSP2. Transcription initiated from the
weaker HSP2 promoter is reported to produce near genomic-
length primary H-strand transcripts, which are processed to
yield the individual ribosomal RNA (rRNA), transfer RNA (tRNA),
and messenger RNA (mRNA) species encoded on the H strand
(Montoya et al., 1983; Falkenberg et al., 2007). In contrast, tran-
scription initiated from the stronger HSP1 promoter is terminated
in the tRNAL1 gene immediately downstream of the 12S and 16S
rRNA genes. This transcription termination event is predicted to
explain why the steady-state levels of the 12S and 16S rRNA are
50 times higher than those of themRNAs encoded on the same
strand (Christianson and Clayton, 1988; Kruse et al., 1989; Daga
et al., 1993; Shang and Clayton, 1994). It should be noted that
there is no consensus as of yet about the existence of HSP2
because attempts to reconstruct its activity in vitro have given
conflicting results (Litonin et al., 2010; Zollo et al., 2012), possibly
explained by difficulties in defining physiologically relevant
in vitro transcription reaction conditions (Shi et al., 2012).
Transcription termination on the H strand has been attributed
to mitochondrial transcription termination factor 1 (MTERF1),
which is a DNA-binding protein of 39 kDa that interacts with
a 28 bp region within the tRNAL1 gene, located immediately
downstream of the rRNA genes (Fernandez-Silva et al., 1997).
MTERF1 is also supposed to function as an activator of mito-
chondrial rRNA transcription by forming an rRNA gene-contain-
ing loop that facilitates reinitiation of transcription at HSP1
(Martin et al., 2005). The binding of MTERF1 to its target site
has been reconstituted in a pure recombinant in vitro system
(Asin-Cayuela et al., 2005). Surprisingly, MTERF1 only partially
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opposite direction (L-strand transcription) is almost completely
blocked (Shang and Clayton, 1994; Asin-Cayuela et al., 2005).
There are four members in the vertebrate MTERF family:
MTERF1, MTERF2, MTERF3, and MTERF4 (Linder et al.,
2005). The atomic structures of MTERF1 (Jime´nez-Mene´ndez
et al., 2010; Yakubovskaya et al., 2010), MTERF3 (Spa˚hr et al.,
2010), and a heterodimer between MTERF4 and the 5-methylcy-
tosine rRNAmethyltransferase NSUN4 (Spa˚hr et al., 2012; Yaku-
bovskaya et al., 2012) have revealed that the MTERF proteins
have a half-doughnut shape and contain a positively charged
path on the convex side. In MTERF1, the positively charged
path specifically unwinds the DNA helix and causes base flipping
at its binding site in the tRNAL1 gene (Yakubovskaya et al., 2010),
thus suggesting a mechanism for the transcription termination
activity. AnotherMTERF familymember,MTERF4, forms a stable
heterodimer with NSUN4 (Ca´mara et al., 2011; Spa˚hr et al., 2012)
and is necessary for ribosomal biogenesis.
Despite the quite extensive scientific literature published
during the last two decades, the function of MTERF1 has never
been clearly established in vivo. Very surprisingly, the findings
in Mterf1 knockout mice reported here do not support a role
for MTERF1 in regulation of rRNA synthesis and ribosomal
biogenesis. Instead, our data suggest a model in which the
main function of MTERF1 is to prevent L-strand transcripts
fromproceeding around themtDNA circle and causing transcrip-
tion interference at the LSP promoter fromwhich they originated.
RESULTS AND DISCUSSION
Homozygous Disruption of the Duplicated Mterf1 Gene
MTERF1 is encoded by two adjacent duplicated genes, herein
designated Mterf1a and Mterf1b (Figure 1A). Both genes are
highly homologous (Figure S1A) and are predicted to encode
nearly identical proteins (Figure S1B). We utilized a sequence
difference between the two genes to perform restriction enzyme
digestion of complementary DNA (cDNA) and found that both
Mterf1a andMterf1b were expressed at similar levels in different
tissues (Figure S1C). In addition, we performed northern blot
analysis, which showed that the comigrating Mterf1a and
Mterf1b transcripts (hereafter referred to as Mterf1 transcripts)
were widely expressed (Figure S1D).
With this information at hand, it was evident that gene target-
ing in the mouse would require knockout of both Mterf1a and
Mterf1b in the same mouse embryonic stem cell (ESC) clone.
The peptide coding sequence of Mterf1a and Mterf1b is exclu-
sively located within exon 2; we therefore constructed two sepa-
rate targeting vectors to remove this exon in both genes (Figures
1A and 1B). The two genes are very closely spaced; thus, recom-
bination events in the intragenic region between Mterf1a and
Mterf1b will be extremely rare. We therefore had to ensure that
the targeted Mterf1a and Mterf1b genes were located on the
same chromosome. To this end, ESCs were used to produce
mice, and the segregation of the targeted Mterf1a and Mterf1b
alleles was followed. Heterozygous mice containing both tar-
geted genes on the same chromosome were crossed with
mice with ubiquitous Flp-recombinase expression to excise the
PGK-neo cassette from Mterf1a (Figure 1A). The resulting mice
were crossed with mice ubiquitously expressing b-actin-cre toCdisrupt Mterf1a (Figure 1A). The mice produced from these
crosses thus harbor the disrupted Mterf1a and Mterf1b gene
on the same chromosome and are henceforth referred to as
heterozygous Mterf1 knockouts. To minimize genetic back-
ground effects, heterozygousMterf1 knockout mice were back-
crossed to wild-type C57Bl6/Nmice for six generations and then
intercrossed to produce homozygous knockouts, hereafter
referred to as Mterf1 knockout mice. We documented that
Mterf1 knockout mice lack Mterf1 transcripts by performing
northern blots (Figure 1C) and RT-PCR analyses (Figure 1D).
Consistent with the lack of transcripts, we found that Mterf1
knockout mice contained no detectable MTERF1 protein
(Figure 1E). Thus, the Mterf1 knockout mice completely lack
MTERF1 expression fromMterf1a andMterf1b and are therefore
complete knockouts.
Mterf1 Knockout Mice Are Viable with Normal Oxidative
Phosphorylation Capacity
Given the many reports of important functions for MTERF1 in
regulation of mtDNA expression (Christianson and Clayton,
1988; Kruse et al., 1989; Hess et al., 1991; Shang and Clayton,
1994; Valverde et al., 1994; Fernandez-Silva et al., 1997; Asin-
Cayuela et al., 2005; Martin et al., 2005), it was very surprising
that Mterf1 knockout mice were viable and apparently healthy,
as documented by normal weight gain (Figure 2A). Given that
moderately reduced oxidative phosphorylation capacity can
give no, or very minor, phenotypes in mutant mice (Larsson
et al., 1998; Freyer et al., 2010; Sterky et al., 2012), we made
a detailed evaluation of respiratory chain enzyme activities (Fig-
ure 2B) and substrate-stimulated respiration in isolated heart
mitochondria (Figure 2C) but found no differences between
Mterf1 knockout and control mice. MTERF1 is highly expressed
in liver (Figure S1D) but, also in this organ, we found normal
respiratory chain function in the absence of MTERF1 (Figures
S2A and S2B). Furthermore, we isolatedmitochondria from brain
and skeletal muscle to assess levels of assembled respiratory
chain complexes with blue native PAGE (BN-PAGE) and found
no differences between Mterf1 knockout and control mice
(Figure 2D). Although the analyses of respiratory chain function
in isolated mitochondria from different tissues showed no
difference between Mterf1 knockout and control mice (Figures
2B–2D, S2A, and S2B), these findings do not exclude that
the total oxidative phosphorylation capacity per cell may be
altered. To investigate this possibility, we isolated splenocytes
and measured respiration in intact, mildly permeabilized cells
(Figures 2E and 2F); again, we found no difference between
Mterf1 knockout and control mice. To summarize, analysis of
several different tissues in Mterf1 knockout animals showed
that loss of MTERF1 had no impact on oxidative phosphorylation
capacity.
MTERF1 Is Dispensable for Maintenance and
Replication of mtDNA
The lack of effects in the knockout mouse prompted us to
reexamine how MTERF1 binds mtDNA. We studied the intracel-
lular localization of DsRed2-tagged MTERF1 in tissue culture
cells and found that it forms discrete spots within mitochon-
dria (Figure S3A). These spots predominantly colocalize with
mitochondrial nucleoids (Figure S3B), consistent with MTERF1ell Metabolism 17, 618–626, April 2, 2013 ª2013 Elsevier Inc. 619
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Figure 1. Creation of Mterf1 Knockout Mice
(A) Targeting of the Mterf1a and Mterf1b genes.
(B) Screening of homologous recombination at the Mterf1a and Mterf1b loci in ESCs.
(C) Northern blot analysis of Mterf1 mRNA expression in wild-type and Mterf1 knockout mice.
(D) Quantitative PCR (qPCR) analysis of Mterf1 mRNA expression in wild-type and Mterf1 knockout mice.
(E) Western blot analysis of MTERF1 protein expression in liver from wild-type and Mterf1 knockout mice.
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MTERF1 Blocks Transcriptional Interference at LSPbeing a DNA-binding protein (Jime´nez-Mene´ndez et al., 2010;
Yakubovskaya et al., 2010). To define the exact mtDNA bind-
ing sites, we used chromatin immunoprecipitation followed
by next-generation sequencing (ChIP-seq) and found a very
prominent interaction within the tRNAL1 gene (Figure 3A),
consistent with the known location of the MTERF1 binding
site (Fernandez-Silva et al., 1997; Asin-Cayuela et al., 2005).
However, in contrast to a previous report (Martin et al., 2005),
we observed no MTERF1 binding to the promoter region of
mtDNA (Figure 3A). Despite its specific interaction with mtDNA,
loss of MTERF1 had no effect on mtDNA levels (Figures 3B
and 3C).620 Cell Metabolism 17, 618–626, April 2, 2013 ª2013 Elsevier Inc.MTERF1 Does Not Affect the Biogenesis of
Mitochondrial rRNAs
The experimental results forced us to question the idea that
MTERF1 interacts with the promoter region and stimulates
HSP1 transcription by facilitating mtDNA loop formation (Martin
et al., 2005). Very unexpectedly, we found normal steady-state
levels of mitochondrial 12S rRNA, 16S rRNA, and various
mRNAs inMterf1 knockout mice (Figures 3D and 3E). Mitochon-
drial de novo transcription (Figures 3F and 3G), mainly reflecting
H-strand transcription, and steady-state levels of tRNAs (Figures
3H and 3I), a good indicator of transcription initiation events
(Ca´mara et al., 2011; Ruzzenente et al., 2012), were not altered
A0
10
20
30
40
5 10 15 20
B
od
y 
w
ei
gh
t (
g)
Age (week)
B
od
y 
w
ei
gh
t (
g)
Age (week)
0
10
20
30
40
5 10 15 20
B
0 
20 
40 
60 
80 
100 
120 
Compl I 
NQR 
Compl I/III 
NCR 
Compl II 
SDH 
Compl II/III 
SCR 
Compl IV 
COX 
0 
20 
40 
60 
80 
100 
120 
140 
G+S G+M T+A P+M PC+M S+R S 
C
D E
F
0 
50 
100 
150 
200 
250 
300 
350 
PGM3 PGM4 PGMc 
JO
2 
(p
at
O
/m
in
/M
ce
lls
) 
WT
KO
0 
100 
200 
300 
400 
500 
600 
JO
2 
(p
at
O
/m
in
/M
ce
lls
) 
WT
KO 
Re
la
tiv
e 
en
zy
m
e 
ac
tiv
ity
 (A
U
)
Re
la
tiv
e 
AT
P 
pr
od
uc
tio
n 
(A
U
)
WT
KO
WT
KO
WT
KO
WT
KO
WTKO KO
669
440
232
140
M
ar
ke
r
Skeletal Muscle
WT
Brain
IxIIIyIVz
I
V
}
}
}
Figure 2. Phenotypic Characterization of
Mterf1 Knockout Mice
(A) Weight curves for wild-type and Mterf1
knockout mice (n = 5 males and n = 5 females per
genotype). Error bars = SEM.
(B) Measurement of respiratory chain enzyme
activities in wild-type (n = 5) and Mterf1 knockout
(n = 5) mice. The relative enzyme activities for
NADH-coenzymeQ reductase (complex I), NADH-
cytochrome c reductase (complexes I and III),
succinate dehydrogenase (complex II), succinate-
cytochrome c reductase (complexes II and III), and
cytochrome c oxidase (complex IV) are shown.
Error bars = SEM.
(C) Measurement of mitochondrial ATP production
rate in wild-type (n = 5) andMterf1 knockout (n = 5)
mice with glutamate and succinate (G+S),
glutamate and malate (G+M), tetramethyl-p-
phenylenediamine (TMPD) and ascorbate (T+A),
pyruvate and malate (P+M), palmitoyl-L-carnitine
and malate (PC+M), succinate and rotenone
(S+R), and succinate (S). Error bars = SEM.
(D) BN-PAGE analysis of levels of assembled
respiratory chain complexes from wild-type (n = 3)
and Mterf1 knockout (n = 3) mice.
(E) Oxygen consumption in whole splenocytes
isolated fromwild-type andMterf1 knockout mice.
Cells were incubated with pyruvate, glutamate,
and malate (PGM) to deliver electrons to complex
I. Permeabilized cell respiration was analyzed
in the phosphorylating (state 3; PGM3), non-
phosphorylating (state 4; PGM4), and uncoupled
(PGMc) states. Error bars = SEM.
(F) Oxygen consumption in whole splenocytes
isolated fromwild-type andMterf1 knockout mice.
Cells were incubated with succinate and rotenone
to deliver electrons to complex II. Permeabilized
cell respiration was analyzed in the phosphory-
lating (state 3; S3), nonphosphorylating (state 4;
S4), and uncoupled (Sc) states. Error bars = SEM.
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MTERF1 Blocks Transcriptional Interference at LSPin the absence of MTERF1. We also investigated mitochondrial
de novo translation by in organello experiments (Figure S3C)
and steady-state levels of respiratory chain protein subunits (Fig-
ure S3D) and found no difference betweenMterf1 knockout and
control mice. These findings are consistent with a report showing
that partial knockdown of MTERF1 in cell lines creates no clear
effect on steady-state levels of mitochondrial rRNAs (Hyva¨rinen
et al., 2010).
We performed in vivo footprinting analyses to address the
possibility that another protein could occupy the MTERF1
binding site in Mterf1 knockout cells. Mouse embryonic fibro-
blasts (MEFs) from Mterf1 knockout and control animals were
transfected with a gene encoding a mitochondrially targeted
cystosine DNA methyltransferase (Rebelo et al., 2009). Next,Cell Metabolism 17, 618–mtDNA was isolated and treated with
bisulphite followed by PCR amplification
and sequencing. In wild-type MEFs, we
found clear protection of critical cyto-
sines (Figure 3J) at the site where
MTERF1 is known to bind mtDNA (Yaku-
bovskaya et al., 2010). However, noprotection of this site was found in Mterf1 knockout MEFs (Fig-
ure 3K), thus showing that there is no other protein binding to
this site when MTERF1 is absent. Taken together, the findings
inMterf1 knockout mice do not support the model that MTERF1
regulates ribosomal biogenesis in vivo by modifying H-strand
transcription initiation and termination.
MTERF1 Prevents Transcriptional Interference at
the LSP
Given the lack of effects on H-strand transcription in Mterf1
knockout mice, we proceeded to assess transcription from the
LSP. We found a substantial decrease of transcription imme-
diately downstream of the LSP by S1 nuclease protection
assays of RNA from Mterf1 knockout mice (Figure 4A). We also626, April 2, 2013 ª2013 Elsevier Inc. 621
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Figure 3. Analysis of MTERF1 DNA-Binding Sites and mtDNA Expression
(A) ChIP-seq profile of MTERF1 binding to mtDNA. MTERF1 reads were normalized against no-antibody control. Peak detection was performed using
CisGenome (reads per million [RPM]).
(B) Levels of mtDNA in wild-type (n = 5) and Mterf1 knockout (n = 5) mice measured by Southern blot analysis.
(legend continued on next page)
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MTERF1 Blocks Transcriptional Interference at LSPperformed northern blots, which showed decreased abundance
of the LSP-proximal 7S RNA transcript in Mterf1 knockout
animals (Figure 4B). These findings indicate a decrease in tran-
scription initiation events at the LSP, consistent with previous
reports from us showing a strong correlation between de novo
transcription activity and 7S RNA levels (Ca´mara et al., 2011;
Park et al., 2007; Wredenberg et al., 2013; Ruzzenente et al.,
2012). This decrease in transcription initiation is apparently toler-
ated in Mterf1 knockout animals, as both mtDNA levels (Figures
3B and 3C), depending on RNA primer formation to initiate repli-
cation, and L-strand transcript levels (ND6 and tRNAQ) were
normal (Figures 3D, 3E, 3H, and 3I). The finding of decreased
levels of promoter-proximal LSP transcripts could indicate that
this promoter is subject to promoter interference. We therefore
investigated levels of L-strand transcripts downstream of the
termination site where MTERF1 is normally binding. In Mterf1
knockout mice, we detected a 2- to 3-fold increase in the levels
of such transcripts, which are antisense to the rRNA gene region,
by using northern blots with oligonucleotide probes (Figures 4C,
4D, and S4A).
We tested the possibility that MTERF1 could be of critical
importance when the demands for oxidative phosphorylation
are high by feeding Mterf1 knockout and control mice a keto-
genic diet for9months. This is a high-fat and low-carbohydrate
diet, which causes a shift towards oxidative phosphorylation
(Laffel, 1999; Kennedy et al., 2007). This diet successfully
provokes phenotypes inMterf2 knockout animals that are nearly
asymptomatic in standard housing conditions (Wenz et al.,
2009). Glucose tolerance tests (Figure S4B) and standard clinical
chemistry blood parameters (Figure S4C) showed no significant
differences betweenMterf1 knockout and control animals on the
ketogenic diet. Furthermore, steady-state levels of mtDNA (Fig-
ure S4D), mitochondrial transcripts (Figure S4E), and respiratory
complexes (Figure S4F) were similar in Mterf1 knockout and
control animals on the ketogenic diet. These findings do not
exclude that subtle differences in the oxidative phosphorylation
capacity, which may be difficult to measure with available
methods, could confer a selective advantage in the wild.
Transcription of mtDNA Is Dependent on Mechanisms
Preventing Elongating Transcription Complexes from
Reaching the Promoters
The experiments presented here contradict the idea that
MTERF1 regulates initiation and termination of transcripts pro-
duced from HSP1 (Christianson and Clayton, 1988; Kruse et al.,
1989; Daga et al., 1993; Shang and Clayton, 1994), as rRNA tran-
script levels remained unaffected in Mterf1 knockout mice.
Instead, loss of MTERF1 leads to an increase in the RNA levels
downstream of the termination site at the L strand (Figures 4C
and 4D). A possible explanation for this effect comes from the(C) Quantification of mtDNA levels in wild-type and Mterf1 knockout mice. Error
(D) Northern blot analysis of levels of rRNAs and mRNAs in wild-type (n = 6) and
(E) Quantification of levels of rRNAs and mRNAs in wild-type and Mterf1 knocko
(F) In organello analysis of de novo transcription in wild-type (n = 3) and Mterf1 k
(G) Quantification of de novo transcription in wild-type and Mterf1 knockout mic
(H) Northern blot analysis of levels of tRNAs in wild-type (n = 6) and Mterf1 knoc
(I) Quantification of levels of tRNAs in wild-type and Mterf1 knockout mice. Error
(J) Methylation assay to assess cytosine methylation protection at the binding si
(K) Methylation assay to assess cytosine methylation protection at the binding s
Cobservation that the termination activity ofMTERF1 has a distinct
polarity and most effectively blocks transcription coming from
the LSP direction (Figure 4E). The decrease in LSP transcripts
seen in the Mterf1 knockout mice could therefore be explained
by a model in which MTERF1 terminates L-strand transcription
at its binding site in tRNAL1 and thereby prevents elongating
L-strand transcription complexes from interfering with transcrip-
tion initiation at the LSP (Figure 4E). Termination at this site may
also block the synthesis of antisense rRNA transcripts that pos-
sibly could interfere with ribosomal maturation and/or function.
Studies of bacteriophage RNA polymerases have shown that
they can bypass each other when they transcribe the same
DNA template and meet head-on (Ma and McAllister, 2009). It
is therefore possible that simultaneous transcription from the
LSP and HSP may occur on the same mtDNA template. This
finding may also explain why L-strand transcription past the
MTERF1 binding site has no deleterious effects on HSP tran-
scription in Mterf1 knockout animals. Contrary to the tolerance
for head-on collisions, bacteriophage RNA polymerases tran-
scribing the same strand may interfere with each other (Zhou
and Martin, 2006). In particular, stalled polymerases may be dis-
placed by a second trailing polymerase, which may impair tran-
scription initiation (Zhou and Martin, 2006). It is interesting to
note that H-strand transcription is also terminated before it rea-
ches HSP, as there is a block preventing elongation of H-strand
transcription past the termination-associated sequence (TAS)
(Freyer et al., 2010). These findings suggest that mechanisms
have evolved to prevent elongating L-strand and H-strand tran-
scription complexes from reaching the LSP and HSP, respec-
tively, as this would interfere with transcription initiation events.
EXPERIMENTAL PROCEDURES
Creation of Mterf1 Knockout Mice
We identified a bacterial artificial clone (BAC) containing the Mterf1a and
Mterf1b genes in a 129Sv RPCI-22M BAC library (Invitrogen) by using a
cDNA probe. A 12.4 kb EcoRI fragment containing all exons of Mterf1a
was cloned into pBluescript II SK+ (Stratagene) to generate pBS-T1a. An
oligonucleotide was inserted at the PacI site of pBS-T1a in order to intro-
duce a loxP site in the intron following exon 2, thus creating the plasmid
pBS-T1aLoxP. Next, the Frt-PGK-neo-Frt-loxP cassette (Frt site-flanked
neomycin resistance gene with an adjacent loxP site) was inserted into the
KpnI site of pBS-T1aLoxP. Finally, a KpnI fragment containing the Frt-PGK-
neo-Frt-loxP cassette was excised from a modified pDELBOY-3X plasmid
containing a KpnI site introduced into the XhoI site, thus creating the final
Mterf1a targeting vector, pBS-T1aKO. A 13.6 kb KpnI fragment containing
all exons of the Mterf1b gene was cloned into pBluescript II SK+ (Stratagene)
to generate pBS-T1b. A 3.3 kb SfiI/SpeI fragment containing exon 2 ofMterf1b
was replaced with a hygromycin resistance cassette, thus creating pBS-
T1bKO.
The vector pBS-T1bKOwas used to transfect ESCs, and genomic DNA was
isolated and digested with ScaI. Digested DNA was transferred to nylon
membranes by Southern blotting and probed with probe 2 (Figure 1B). Onebars = SEM.
Mterf1 knockout (n = 6) mice.
ut mice. Error bars = SEM.
nockout (n = 3) mice.
e. Error bars = SEM.
kout (n = 6) mice.
bars = SEM.
te for MTERF1 in cell lines from wild-type mice.
ite for MTERF1 in cell lines from Mterf1 knockout mice.
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Figure 4. Analysis of Transcription Initiation at the LSP
(A) S1 protection assay (left panel) and quantification of this analysis (right panel) to determine relative levels of the LSP-proximal 7S RNA transcript. Error bars
indicate SEM. Student’s t test was used for statistical analysis: **p < 0.01.
(B) Northern blot analysis (left panel) and quantification of this analysis (right panel) to determine relative levels of the LSP-proximal 7S RNA transcript. Error bars
indicate SEM. Student’s t test was used for statistical analysis: **p < 0.01.
(C) Northern blot analyses to assess the levels of L-strand transcripts downstream of the MTERF1 binding site.
(D) Quantification of northern blot analyses to assess the levels of L-strand transcripts downstream of the MTERF1 binding site. Error bars indicate SEM.
Student’s t test was used to assess statistical significance: **p < 0.01, ***p < 0.001.
(E) Proposed model for the mode of action of MTERF1 (upper panel) and the transcriptional consequences of loss of MTERF1 (lower panel).
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MTERF1 Blocks Transcriptional Interference at LSPspecifically targeted clone was found among a total of 145 analyzed ESC
clones. Next, pBS-T1aKO was used to transfect ESCs whereMterf1b already
had been targeted, and Mterf1a-targeted ESC clones were identified by
Southern blot analysis.
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